Form 10-K RHYTHM PHARMACEUTICALS, For: Dec 31
Rhythm Pharmaceuticals, Inc. (RYTM)
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.rhythmtx.com
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
RYTM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RYTM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RYTM alerts
High impacting Rhythm Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RYTM
News
- Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $72.00 price target on the stock.MarketBeat
- Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $78.00 price target on the stock.MarketBeat
- Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at HC Wainwright from $69.00 to $70.00. They now have a "buy" rating on the stock.MarketBeat
- Rhythm Pharmaceuticals Inc (RYTM) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]Yahoo! Finance
- Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Canaccord Genuity Group Inc. from $80.00 to $81.00. They now have a "buy" rating on the stock.MarketBeat
RYTM
Earnings
- 2/26/25 - Miss
RYTM
Sec Filings
- 2/28/25 - Form S-8
- 2/28/25 - Form 8-K
- 2/26/25 - Form 8-K
- RYTM's page on the SEC website